Vertex Pharmaceutic (VRTX) 94.51 $VRTX Zacks.com

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vertex Pharmaceutic (VRTX) 94.51 $VRTX

Zacks.com featured highlights: Covanta Holding, ZELTIQ Aesthetics, Capital Senior Living, Live Nation Entertainment and Vertex Pharmaceuticals
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:30AM CDT
Zacks.com featured highlights: Covanta Holding, ZELTIQ Aesthetics, Capital Senior Living, Live Nation Entertainment and Vertex Pharmaceuticals
CSU: 17.19 (-0.26), CVA: 14.89 (+0.10), VRTX: 94.51 (-1.29), ZLTQ: 38.12 (-0.28), LYV: 26.72 (unch)

5 Toxic Stocks to Steer Clear Of Before It's Too Late
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:25AM CDT
Overpricing of toxic stocks can be ascribed to either an irrational exuberance associated with them or some serious fundamental drawbacks.
CVA: 14.89 (+0.10), CSU: 17.19 (-0.26), VRTX: 94.51 (-1.29), ZLTQ: 38.12 (-0.28), LYV: 26.72 (unch)

Stock Market News for August 25, 2016
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 8:55AM CDT
Benchmarks ended in the red on Wednesday following decline in Mylan’s shares, which had a negative impact on the biotech stocks and eventually on the broader healthcare sector
FIT: 15.48 (+0.11), ENDP: 20.70 (-0.19), VRTX: 94.51 (-1.29), GILD: 78.38 (+0.46), CEO: 120.09 (-1.77), MYL: 42.36 (-0.39), ILMN: 168.34 (-0.65), SDRL: 2.41 (-0.06), HPQ: 14.37 (-0.01), PVH: 107.76 (-0.16)

Vertex Pharmaceuticals Set to Possibly Pullback After Yesterday's Rally of 2.89%
Comtex SmarTrend(R) - Mon Aug 22, 1:33PM CDT
Vertex Pharmaceuticals (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $98.00 to a high of $101.80. Yesterday, the shares gained 2.9%, which took the trading range above the 3-day high of $100.36 on volume of 704,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VRTX: 94.51 (-1.29)

The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 8:30AM CDT
The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen
VRTX: 94.51 (-1.29), AUPH: 1.94 (-0.01), AVEO: 0.93 (-0.02), AMGN: 170.06 (-0.70)

Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data
Arpita Dutt - Zacks Investment Research - Wed Aug 17, 2:49PM CDT
With second quarter earnings season drawing to a close, focus in back on pipeline and regulatory updates.
BIIB: 305.63 (-2.23), VRTX: 94.51 (-1.29), AUPH: 1.94 (-0.01), OGXI: 0.54 (-0.03), GILD: 78.38 (+0.46), AVEO: 0.93 (-0.02), AMGN: 170.06 (-0.70)

TJX and Hain Celestial stumble, G&K Services surges
AP - Tue Aug 16, 3:57PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday:
KMI: 21.85 (-0.06), VRTX: 94.51 (-1.29), DKS: 58.60 (-0.20), GK: 97.33 (+0.06), PX: 122.04 (-0.48)

Vertex (VRTX) To Stop VX-661-Ivacaftor Study, Stock Down
Arpita Dutt - Zacks Investment Research - Tue Aug 16, 9:25AM CDT
Vertex's (VRTX) shares were down in pre-market trading on the company's announcement that it will be stopping one of the phase III studies on its VX-661-ivacaftor combination.
VRTX: 94.51 (-1.29), ANIP: 59.74 (-1.12), GERN: 2.69 (unch), ANIK: 47.24 (-0.21)

Vertex Pharmaceuticals Falls 2.65% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Aug 10, 2:34PM CDT
Vertex Pharmaceuticals (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $99.72 to a high of $102.78. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $99.77 on volume of 337,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VRTX: 94.51 (-1.29)

Look for Shares of Vertex Pharmaceuticals to Potentially Rebound after Yesterday's 2.65% Sell Off
Comtex SmarTrend(R) - Wed Aug 10, 2:33PM CDT
Vertex Pharmaceuticals (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $99.72 to a high of $102.78. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $99.77 on volume of 337,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VRTX: 94.51 (-1.29)

Kroll Bond Rating Agency Assigns Preliminary Ratings to MSCI 2016-UBS11
BusinessWire - Mon Aug 08, 9:56AM CDT
Kroll Bond Rating Agency (KBRA) is pleased to announce the assignment of preliminary ratings to 16 classes of the MSCI 2016-UBS11 transaction. MSCI 2016-UBS11 is a $719.8 million CMBS conduit transaction collateralized by 38 commercial mortgage loans secured by 75 properties.
VRTX: 94.51 (-1.29)

Vertex Pharmaceuticals Set to Possibly Pullback After Yesterday's Rally of 1.35%
Comtex SmarTrend(R) - Wed Aug 03, 1:43PM CDT
Vertex Pharmaceuticals (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $99.12 to a high of $101.50. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $99.45 on volume of 684,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VRTX: 94.51 (-1.29)

Nivalis (NVLS) Reports Wider-than-Expected Loss in Q2
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:28AM CDT
Nivalis Therapeutics (NVLS) reported a wider-than-expected second-quarter 2016 loss of 55 cents per share.
VRTX: 94.51 (-1.29), ANIP: 59.74 (-1.12), NVLS: 6.39 (+0.08), ANIK: 47.24 (-0.21)

Ophthotech Announces Election of Ian F. Smith, Vertex Executive Vice President and Chief Financial Officer, to Its Board of Directors
BusinessWire - Tue Aug 02, 6:30AM CDT
Ophthotech Corporation (Nasdaq:OPHT) today announced the election of Ian F. Smith, Executive Vice President and Chief Financial Officer of Vertex Pharmaceuticals, to its Board of Directors, effective immediately. Mr. Smith has also been elected the Chair of the Ophthotech Audit Committee.
VRTX: 94.51 (-1.29), OPHT: 52.81 (-0.56)

Research Report Coverage on Select Biotech Stocks -- Vertex Pharma, Infinity Pharma, Aduro BioTech, and Aralez Pharma
PR Newswire - Mon Aug 01, 7:05AM CDT
The Biotech industry is where investors come out either short or confidently strong. Following its fall in September 2015, the industry is now signaling a pullback, suggesting to the investor community that buying opportunities are available. Additionally, the sector finished on a solid note in July 2016, up 10%. Today, Stock-Callers.com has the following equities on its radar for further assessment: Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), Infinity Pharmaceuticals Inc. (NASDAQ: INFI), Aduro BioTech Inc. (NASDAQ: ADRO), and Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ). These stocks research reports can be downloaded now by simply registering for free at:
VRTX: 94.51 (-1.29), ADRO: 14.09 (+0.14), ARLZ: 4.97 (-0.07), INFI: 1.52 (-0.08)

Vertex (VRTX) Posts Narrower Q2 Loss, Revenues Fall Short
Arpita Dutt - Zacks Investment Research - Thu Jul 28, 6:13AM CDT
Although total revenues were just shy of expectations, Vertex's (VRTX) CF franchise sales improved sequentially.
BIIB: 305.63 (-2.23), VRTX: 94.51 (-1.29), INVA: 11.09 (+0.08), ANIP: 59.74 (-1.12)

Nivalis (NVLS): Can the Stock Surprise This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 5:46PM CDT
Nivalis Therapeutics (NVLS), which is expected to report second-quarter 2016 results on Aug 1, posted a negative surprise of 15.91% last quarter.
VRTX: 94.51 (-1.29), NVLS: 6.39 (+0.08), UTHR: 122.28 (+0.37), BMY: 57.39 (+0.15)

Vertex Reports Second Quarter 2016 Financial Results
BusinessWire - Wed Jul 27, 3:01PM CDT
---Vertex reiterates 2016 guidance for ORKAMBI product revenues of $1.0 to $1.1 billion and KALYDECO product revenues of $685 to $705 million-
VRTX: 94.51 (-1.29)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 14

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
Fluence Energy Faces Heat: Class Action Lawsuit Unfolds

Updated Category News Views 25

Fluence Energy's Difficult Waters Investors in Fluence Energy (NASDAQ: FLNC) are having a moment of reckoning, no doubt. November 2nd saw a nearly 9% drop in FLNC stock, further fueled by the sudden departures of the CEO and CFO just days earlier. This marks a bitter chapter for Fluence as its stock continues to bleed, leaving many wondering what seismic shifts are yet to...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 193

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
Salvation Army’s Angel Tree: 2026 Holiday Cheer Drive

Updated Category News Views 9

Kickstarting Holiday Generosity: The Angel Tree Program Man, there's something heartwarming about a Christmas that shines bright for everyone. The Salvation Army's Angel Tree program is back for another season, rolling up with a mission to spark joy across the country. For over 45 years now, this initiative's been the answer to many Christmas wish lists, especially for...

Continue Reading
Veritran's Bold Move: Acquiring PrismaCampaigns Inc.

Updated Category News Views 58

Veritran's Strategic Leap Forward They're not messing around, folks. Veritran just made a power move by acquiring 100% of PrismaCampaigns Inc., and it’s more than just another day in the office. This marks a pivotal expansion of their American footprint, and they're zeroing in on our banks and credit unions with laser precision. Why This Matters for Financial...

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 74

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 117

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Cinmoore's Smart Camera: A Game Changer for Car Security

Updated Category News Views 32

Pioneering Car Security with Cinmoore's Smart Camera Ever left your car in the parking lot, heart pounding, wondering if it's safe while you run errands? Well, Cinmoore might just quell that parking paranoia with their new gizmo, the Smart Parking Camera DC1U. This device isn't just some fancily-packaged disappointment—it promises some serious peace of mind for those...

Continue Reading
Ballard's Q3 2026: Navigating Losses and Bold Moves

Updated Category News Views 80

Ballard’s Financial Puzzles in Q3 2026 Riding the rough waters of the third quarter in 2026, Ballard Power Systems set out its stall with some eyebrow-raising numbers. This ain't the bustling diner vibe we normally see for a thriving business. The results paint a cautious picture sprinkled with strategic shifts that demand a keen eye. GeoPura Acquisition: A Strategic...

Continue Reading
Baidu's Q3 2026: AI Explodes Amid Marketing Slump

Updated Category News Views 35

Baidu Looks to AI as Revenue Driver in Q3 2026 You know, Baidu's got one heck of a story this quarter. Despite some clouds hanging over them, they’ve managed to find a silver lining in their AI ventures. It’s like they’ve got this magic bullet with AI Cloud growth skyrocketing 94% year over year. That’s not just a rabbit outta the hat; it’s more like pulling a...

Continue Reading

Top 5 Most Recently Viewed Articles

AEX Index Climbs as Technology Sector Shines Bright

Updated Category News Views 246

AEX Index Climbs as Technology Sector Shines Bright The AEX index in the Netherlands showcased a remarkable performance following gains across multiple sectors during a recent trading session. The technology, consumer goods, and consumer services sectors were significant contributors to this upward trend, reflecting the overall market optimism. Market Performance Overview...

Continue Reading
Comoto Partners with Motorcycle Industry Council to Boost Riding

Updated Category News Views 337

Comoto and the MIC Collaborate for Motorcycling Growth The Comoto Family of Brands, which includes names like Cycle Gear, RevZilla, and J&P Cycles, has recently announced an exciting partnership with the Motorcycle Industry Council (MIC). This collaboration aims to ignite the passion for motorcycle riding among new and potential riders through innovative educational...

Continue Reading
Oxford Treatment Center Launches Evening Addiction Services

Updated Category News Views 288

Oxford Treatment Center Enhances Addiction Care Availability Oxford Treatment Center is excited to announce the launch of its new evening intensive outpatient program (IOP), designed specifically for those in Southaven seeking flexible addiction care. This initiative addresses a crucial gap in services for individuals juggling daytime obligations, such as work or school,...

Continue Reading
Anticipating Earnings: Insights for MeridianLink (MLNK)

Updated Category News Views 146

MeridianLink's Earnings Outlook MeridianLink (NYSE: MLNK) is gearing up to announce its quarterly earnings soon, which has investors excited about what lies ahead. As the moment approaches, there are critical factors that stakeholders should consider to navigate the upcoming report effectively. Anticipated Earnings Analysis Expectations are set for MeridianLink to unveil...

Continue Reading
BCT - The Community's Bank Celebrates Loudoun's Favorite Honors

Updated Category News Views 145

BCT - The Community's Bank Wins Loudoun's Favorite Awards BCT - The Community's Bank has been recognized by residents as one of Loudoun's Favorite banks, having won multiple awards in the recent annual reader's poll. This recognition reflects the bank's unwavering dedication to providing top-notch financial services to its local community. For the second consecutive year,...

Continue Reading